
Published by
Benzinga
Benzinga
GainersBenitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares jumped 91.9% to $16.20. TRxADE HEALTH issued correction to press release announcing its anticipated combination with Superlatus, Inc.MoonLake Immunotherapeutics (NASDAQ: MLTX) gained 75% to $45.50 after the company’s Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.INVO Bioscience, Inc. (NASDAQ: INVO) shares j…